共 37 条
- [31] Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)TRIALS, 2024, 25 (01)Zapata-Arriaza, ElenaMedina-Rodriguez, ManuelMoniche alvarez, Franciscode Alboniga-Chindurza, AsierAguilar-Perez, MartaAinz-Gomez, LeireBaena-Palomino, PabloZamora, AynaraPardo-Galiana, BlancaDelgado-Acosta, FernandoValverde Moyano, RobertoJimenez-Gomez, ElviraBravo Rey, IsabelOteros Fernandez, RafaelEscudero-Martinez, IreneVielba-Gomez, IsabelMorales Caba, LluisDiaz Perez, JoseGarcia Molina, EstefaniaMosteiro, SoniaCastellanos Rodrigo, Maria del MarAmaya Pascasio, LauraHidalgo, CarlosFreijo Guerrero, Maria del MarGonzalez Diaz, EvaRamirez Moreno, Jose MariaFernandez Prudencio, LuisTerceno Izaga, MikelBashir Viturro, SaimaGamero-Garcia, Miguel angelJimenez Jorge, SilviaRosso Fernandez, ClaraMontaner, JoanGonzalez Garcia, Alejandro
- [32] Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)Trials, 25Elena Zapata-ArriazaManuel Medina-RodríguezFrancisco Moniche ÁlvarezAsier de Albóniga-ChindurzaMarta Aguilar-PérezLeire Ainz-GómezPablo Baena-PalominoAynara ZamoraBlanca Pardo-GalianaFernando Delgado-AcostaRoberto Valverde MoyanoElvira Jiménez-GómezIsabel Bravo ReyRafael Oteros FernándezIrene Escudero-MartínezIsabel Vielba-GomezLluis Morales CabaJose Díaz PérezEstefania García MolinaSonia MosteiroMaría del Mar Castellanos RodrigoLaura Amaya PascasioCarlos HidalgoMaría del Mar Freijo GuerreroEva González DíazJose María Ramírez MorenoLuis Fernández PrudencioMikel Terceño IzagaSaima Bashir ViturroMiguel Ángel Gamero-GarcíaSilvia Jiménez JorgeClara Rosso FernándezJoan MontanerAlejandro González García
- [33] Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3) (vol 77, pg 855, 2017)JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 301 - 301Blauvelt, A.Gooderham, M.Iversen, L.
- [34] The efficacy and safety of total glucosides of peony in the treatment of primary Sjogren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial (vol 37, pg 1, 2018)CLINICAL RHEUMATOLOGY, 2019, 38 (02) : 617 - 618Liu, XiaLi, XiaomeiLi, XiangpeiLi, ZhijunZhao, DongbaoLiu, ShengyunZhang, MiaojiaZhang, FengxiaoZhu, PingChen, JinweiWei, WeiLin, BingZhou, YingboChen, JingPang, YafeiZhang, LeiSun, XiaoxuanYu, ZhiboJia, YunWang, JiaSun, WenwenChiu, FrankPang, LipingWang, Guochun
- [35] Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial (vol 393, pg 1128, 2019)LANCET, 2019, 393 (10178): : 1298 - 1298Hamada, H.Suzuki, H.Onouchi, Y.
- [36] Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label blinded-endpoints, phase 3 trial (vol 393, pg 1128, 2019)LANCET, 2019, 393 (10180): : 1504 - 1504Hamada, H.Suzuki, H.Onouchi, Y.
- [37] The Mig-Etol Study Group. Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial (vol 13, pg 191, 2013)PAIN PRACTICE, 2013, 13 (08) : 673 - 673Ozturk, VErtas, M.Baykan, B.Sirin, H.Ozge, A.